SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Rite Aid Corporation (RAD) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+979.7%).
- 分析师共识目标价 $7.00 (+979.7% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 36/100 其中 1/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✗
健康
25/100
Debt-to-Equity & liquidity
→ Health
估值概览 — RAD
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-13.64
每股账面价值$0.00
每股营收$438.09
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$7.00 (+979.7%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2014 |
$4.60 |
$25.53B |
$249.41M |
1% |
| 2015 |
$41.60 |
$26.53B |
$2.11B |
8% |
| 2016 |
$3.20 |
$30.74B |
$165.47M |
0.5% |
| 2017 |
$0.08 |
$22.93B |
$4.05M |
0% |
| 2018 |
$17.98 |
$21.53B |
$943.47M |
4.4% |
| 2019 |
$-7.99 |
$21.64B |
$-422.21M |
-2% |
| 2020 |
$-8.82 |
$21.93B |
$-469.22M |
-2.1% |
| 2021 |
$-1.87 |
$24.04B |
$-100.07M |
-0.4% |
| 2022 |
$-9.96 |
$24.57B |
$-538.48M |
-2.2% |
| 2023 |
$-13.64 |
$24.09B |
$-749.94M |
-3.1% |
